PAREXEL ANNOUNCES DATE OF FOURTH QUARTER AND FISCAL 2003 EARNINGS RELEASE AND CONFERENCE CALL
BOSTON, MA, July 8, 2003 — PAREXEL International Corporation (Nasdaq: PRXL) will release Fourth Quarter and Fiscal 2003 financial results on Thursday, August 7, 2003 before the opening of trading. The announcement will be available on PAREXEL’s website at www.parexel.com and on the PR Newswire website at www.prnewswire.com.
Following the release of its results, PAREXEL will host a conference call and live webcast at 10:00 a.m. EST to discuss the results. To access the webcast, visit PAREXEL’s website at www.parexel.com, click on the Investor Relations menu and select “Webcasts.” Double-click the microphone labeled “Q4 and Fiscal 2003 PAREXEL International Earnings Conference Call” to begin. This webcast will continue to be accessible for six months following the live broadcast. To participate via telephone, dial (212) 676-4900 and ask to join the PAREXEL quarterly conference call.
PAREXEL is one of the largest biopharmaceutical outsourcing organizations in the world, providing a broad range of knowledge-based contract research, medical marketing and consulting services to the worldwide pharmaceutical, biotechnology and medical device industries. With a commitment to providing solutions that expedite time-to-market and peak market penetration, PAREXEL has developed significant expertise in clinical trials management, data management, biostatistical analysis, medical marketing, clinical pharmacology, regulatory and medical consulting, industry training and publishing and other drug development consulting services. Its information technology subsidiary, Perceptive Informatics, Inc., develops and offers a portfolio of sophisticated and innovative technology-based products and services that facilitate clinical drug development and are designed to decrease time to peak sales. The technology portfolio includes web-based portal solutions and tracking tools, Interactive Voice Response Systems (IVRS), Clinical Trial Management Systems (CTMS), electronic data capture (EDC), and electronic diary solutions. Perceptive also offers advanced medical diagnostics services to assess rapidly and objectively the safety and efficacy of new drugs, biologics, and medical devices in clinical trials. PAREXEL’s integrated services, therapeutic area depth and sophisticated information technology, along with its experience in global drug development and product launch services, represent key competitive strengths. Headquartered near Boston, MA, PAREXEL operates in 58 locations throughout 36 countries around the world, and has approximately 5,100 employees.